STOCK TITAN

BioLife Solutions Inc. - $BLFS STOCK NEWS

Welcome to our dedicated page for BioLife Solutions news (Ticker: $BLFS), a resource for investors and traders seeking the latest updates and insights on BioLife Solutions stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BioLife Solutions's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BioLife Solutions's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.64%
Tags
none
-
Rhea-AI Summary
BioLife Solutions, Inc. has launched a new large-capacity controlled-rate freezer (CRF) called IntelliRate i67C. With a capacity 40% larger than other tabletop CRFs, it fulfills the need for higher volume production of cell therapies. The freezer features a 67-liter volume, the largest touchscreen controller in its class, and offers options for enhanced monitoring and sample management. It expands BioLife's cryogenic freezer platform and supports autologous and allogeneic CGT customers from preclinical research to commercial-scale manufacturing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
Rhea-AI Summary
BioLife Solutions reports Q1 2023 revenue of $37.7 million, a 4% increase over Q1 2022. Adjusted gross margin improves to 37%. The company plans to explore strategic alternatives for ultra-low temperature and cryogenic freezer product lines. Q1 2023 customer highlights include nearly 200 new customer acquisitions and significant growth in evo cold chain shipments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.97%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.71%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.33%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.33%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.99%
Tags
conferences
BioLife Solutions Inc.

Nasdaq:BLFS

BLFS Rankings

BLFS Stock Data

816.76M
32.61M
3.56%
102.15%
7.06%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
BOTHELL

About BLFS

bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.